Switching to Duloxetine From Other Antidepressants

Status:

COMPLETED

Switching to Duloxetine From Other Antidepressants

Lead Sponsor:

Eli Lilly and Company

Conditions:

Major Depressive Disorder

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

A multicentre, randomised, open label study of out-patients with major depression who have failed to respond adequately to antidepressant treatment for their current episode of depression. The study c...

Eligibility Criteria

Inclusion

Inclusion Criteria:
Male and female outpatients of at least 18 years of age, who meet criteria for Major Depressive Disorder (MDD)
Currently non- or only partially-responsive to an SSRI antidepressant after at least 5 weeks of treatment
Exclusion Criteria include:
Current primary Axis I disorder other than MDD
Previous diagnosis of bipolar disorder, schizophrenia, or other psychotic disorders
Patients judged to be at serious suicidal risk.
Serious medical illness

Exclusion

Key Trial Info

Start Date :

August 1 2004

Trial Type :

INTERVENTIONAL

End Date :

March 1 2006

Estimated Enrollment :

360 Patients enrolled

Trial Details

Trial ID

NCT00191932

Start Date

August 1 2004

End Date

March 1 2006

Last Update

July 25 2006

Active Locations (14)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 4 (14 locations)

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician

Caen, France

Cherbourg, France

Palaiseau, France

Paris, France

Trial Details

Trial ID

NCT00191932

Start Date

August 1 2004

End Date

March 1 2006

Last Update

July 25 2006

Status: